Research

Psychedelic Use Associated with Reduced Risk of Heart Disease and Diabetes

Psychedelic Use Associated with Reduced Risk of Heart Disease and Diabetes

Researchers say there are several ways classic psychedelics could, directly and indirectly, lead to improved cardiometabolic health.
How Mindset Pharma Is Making and Defining 'Next-Generation Psychedelic Drugs'

How Mindset Pharma Is Making and Defining ‘Next-Generation Psychedelic Drugs'

CEO James Lanthier compares psychedelic medicines to aspirin, and explains why the company's lead candidate may be better than psilocybin.
World Boxing Association Partners with Psychedelics Company to Improve Brain Injury Treatment for Athletes

World Boxing Association Partners with Psychedelics Company for TBI and PTSD Research

"We believe in the promise of the resurgence of psychedelic medicine and are proud to be collaborating with Lobe Sciences as we work together to improve the lives and health of members of the WBA family," says WBA president Gilberto Jesús Mendoza.
86% of Oregon Adults Considering Psilocybin Are Interested in Microdosing

Majority of Oregon Adults Interested in Psilocybin Want to Try Microdosing

,
On the flip side, 37% of Oregon adults surveyed said they did not know what psilocybin was.
Survey Shows American Psychologists Still Don't Really Understand Psychedelics

Survey Shows American Psychologists Still Don't Really Understand Psychedelics

Less than half of psychologists surveyed agreed that psychedelics showed promise in the treatment of serious mental health issues.

Psyched Wellness to Study Amanita Muscaria Mushroom Extract for Sleep Disorders

Psychoactive compound muscimol has been shown to treat stress and anxiety, ease muscular pain, and promote restorative sleep.
Tim Ferriss and Michael Pollan Team Up to Launch UC Berkeley Psychedelic Journalism Fellowship

Tim Ferriss and Michael Pollan Team Up to Launch UC Berkeley Psychedelic Journalism Fellowship

Podcaster and author of "The 4-Hour Work Week" will gift the university's Center for the Science of Psychedelics $800,000 over 3 years to fund fellowship overseen by Professor Pollan.
UW-Madison Study Aims to Increase Minority Representation in Psychedelic Clinical Trials

UW-Madison Study Aims to Increase Minority Representation in Psychedelic Clinical Trials

"Certain demographic groups have been the recipients of more legal scrutiny related to substance use than the majority of the population,” says lead researcher Cody Wenthur.
WHAT is DMT

Algernon Pharmaceuticals Shows DMT Can Increase Neuron Growth by 40%

The Vancouver-based drug development company is investigating the use of DMT as a possible treatment for stroke.

© 2023 Psychedelic Spotlight. | Owned and operated by PSYC Media Corporation, Inc. a US publicly traded company (OTCPink: PSYC) | All Rights Reserved.